|
1
|
Cerchia C and Lavecchia A: Small molecule
drugs and targeted therapy for melanoma: Current atrategies and
future directions. Curr Med Chem. 24:2312–2344. 2017. View Article : Google Scholar
|
|
2
|
Kalal BS, Upadhya D and Pai VR:
Chemotherapy resistance mechanisms in advanced skin cancer. Oncol
Rev. 11:3262017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li S, Sun W, Wang H, Zuo D, Hua Y and Cai
Z: Research progress on the multidrug resistance mechanisms of
osteosarcoma chemotherapy and reversal. Tumour Biol. 36:1329–1338.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Almasan A and Ashkenazi A: Apo2L/TRAIL:
Apoptosis signaling, biology, and potential for cancer therapy.
Cytokine Growth Factor Rev. 14:337–348. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johnstone RW, Frew AJ and Smyth MJ: The
TRAIL apoptotic pathway in cancer onset, progression and therapy.
Nat Rev Cancer. 8:782–798. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang S: The promise of cancer therapeutics
targeting the TNF-related apoptosis-inducing ligand and TRAIL
receptor pathway. Oncogene. 27:6207–6215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gonzalvez F and Ashkenazi A: New insights
into apoptosis signaling by Apo2L/TRAIL. Oncogene. 29:4752–4765.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kischkel FC, Lawrence DA, Chuntharapai A,
Schow P, Kim KJ and Ashkenazi A: Apo2L/TRAIL-dependent recruitment
of endogenous FADD and caspase-8 to death receptors 4 and 5.
Immunity. 12:611–620. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
LeBlanc HN and Ashkenazi A: Apo2L/TRAIL
and its death and decoy receptors. Cell Death Differ. 10:66–75.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ivanov VN, Bhoumik A and Ronai Z: Death
receptors and melanoma resistance to apoptosis. Oncogene.
22:3152–3161. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dyer MJ, MacFarlane M and Cohen GM:
Barriers to effective TRAIL-targeted therapy of malignancy. J Clin
Oncol. 25:4505–4506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dimberg LY, Anderson CK, Camidge R,
Behbakht K, Thorburn A and Ford HL: On the TRAIL to successful
cancer therapy? Predicting and counteracting resistance against
TRAIL-based therapeutics. Oncogene. 32:1341–1350. 2013. View Article : Google Scholar
|
|
14
|
Guiho R, Biteau K, Heymann D and Redini F:
TRAIL-based therapy in pediatric bone tumors: How to overcome
resistance. Future Oncol. 11:535–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Miguel D, Lemke J, Anel A, Walczak H
and Martinez-Lostao L: Onto better TRAILs for cancer treatment.
Cell Death Differ. 23:733–747. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Keidar M, Walk R, Shashurin A, Srinivasan
P, Sandler A, Dasgupta S, Ravi R, Guerrero-Preston R and Trink B:
Cold plasma selectivity and the possibility of a paradigm shift in
cancer therapy. Br J Cancer. 105:1295–1301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zucker SN, Zirnheld J, Bagati A, DiSanto
TM, Des Soye B, Wawrzyniak JA, Etemadi K, Nikiforov M and Berezney
R: Preferential induction of apoptotic cell death in melanoma cells
as compared with normal keratinocytes using a non-thermal plasma
torch. Cancer Biol Ther. 13:1299–1306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishaq M, Evans MM and Ostrikov KK: Effect
of atmospheric gas plasmas on cancer cell signaling. Int J Cancer.
134:1517–1528. 2014. View Article : Google Scholar
|
|
19
|
Vandamme M, Robert E, Lerondel S, Sarron
V, Ries D, Dozias S, Sobilo J, Gosset D, Kieda C, Legrain B, et al:
ROS implication in a new antitumor strategy based on non-thermal
plasma. Int J Cancer. 130:2185–2194. 2012. View Article : Google Scholar
|
|
20
|
Guerrero-Preston R, Ogawa T, Uemura M,
Shumulinsky G, Valle BL, Pirini F, Ravi R, Sidransky D, Keidar M
and Trink B: Cold atmospheric plasma treatment selectively targets
head and neck squamous cell carcinoma cells. Int J Mol Med.
34:941–946. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ishaq M, Kumar S, Varinli H, Han ZJ, Rider
AE, Evans MD, Murphy AB and Ostrikov K: Atmospheric gas
plasma-induced ROS production activates TNF-ASK1 pathway for the
induction of melanoma cancer cell apoptosis. Mol Biol Cell.
25:1523–1531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hirst AM, Simms MS, Mann VM, Maitland NJ,
O’Connell D and Frame FM: Low-temperature plasma treatment induces
DNA damage leading to necrotic cell death in primary prostate
epithelial cells. Br J Cancer. 112:1536–1545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang M, Holmes B, Cheng X, Zhu W, Keidar M
and Zhang LG: Cold atmospheric plasma for selectively ablating
metastatic breast cancer cells. PLoS One. 8:e737412013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vandamme M, Robert E, Lerondel S, Sarron
V, Ries D, Dozias S, Sobilo J, Gosset D, Kieda C, Legrain B, et al:
ROS implication in a new antitumor strategy based on non-thermal
plasma. Int J Cancer. 130:2185–2194. 2012. View Article : Google Scholar
|
|
25
|
Utsumi F, Kajiyama H, Nakamura K, Tanaka
H, Mizuno M, Ishikawa K, Kondo H, Kano H, Hori M and Kikkawa F:
Effect of indirect nonequilibrium atmospheric pressure plasma on
anti-proliferative activity against chronic chemo-resistant ovarian
cancer cells in vitro and in vivo. PLoS One. 8:e815762013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Torii K, Yamada S, Nakamura K, Tanaka H,
Kajiyama H, Tanahashi K, Iwata N, Kanda M, Kobayashi D, Tanaka C,
et al: Effectiveness of plasma treatment on gastric cancer cells.
Gastric Cancer. 18:635–643. 2015. View Article : Google Scholar
|
|
27
|
Hattori N, Yamada S, Torii K, Takeda S,
Nakamura K, Tanaka H, Kajiyama H, Kanda M, Fujii T, Nakayama G, et
al: Effectiveness of plasma treatment on pancreatic cancer cells.
Int J Oncol. 47:1655–1662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adachi T, Tanaka H, Nonomura S, Hara H,
Kondo S and Hori M: Plasma-activated medium induces A549 cell
injury via a spiral apoptotic cascade involving the
mitochondrial-nuclear network. Free Radic Biol Med. 79:28–44. 2015.
View Article : Google Scholar
|
|
29
|
Kurake N, Tanaka H, Ishikawa K, Kondo T,
Sekine M, Nakamura K, Kajiyama H, Kikkawa F, Mizuno M and Hori M:
Cell survival of glioblastoma grown in medium containing hydrogen
peroxide and/or nitrite, or in plasma-activated medium. Arch
Biochem Biophys. 605:102–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Elustondo PA, Nichols M, Robertson GS and
Pavlov EV: Mitochondrial Ca2+ uptake pathways. J
Bioenerg Biomembr. 49:113–119. 2017. View Article : Google Scholar
|
|
31
|
Bonora M, Wieckowski MR, Chinopoulos C,
Kepp O, Kroemer G, Galluzzi L and Pinton P: Molecular mechanisms of
cell death: Central implication of ATP synthase in mitochondrial
permeability transition. Oncogene. 34:1475–1486. 2015. View Article : Google Scholar
|
|
32
|
Izzo V, Bravo-San Pedro JM, Sica V,
Kroemer G and Galluzzi L: Mitochondrial permeability transition:
New findings and persisting uncertainties. Trends Cell Biol.
26:655–667. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Galluzzi L, Bravo-San Pedro JM, Kepp O and
Kroemer G: Regulated cell death and adaptive stress responses. Cell
Mol Life Sci. 73:2405–2410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Orrenius S, Gogvadze V and Zhivotovsky B:
Calcium and mitochondria in the regulation of cell death. Biochem
Biophys Res Commun. 460:72–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Danese A, Patergnani S, Bonora M,
Wieckowski MR, Previati M, Giorgi C and Pinton P: Calcium regulates
cell death in cancer: Roles of the mitochondria and
mitochondria-associated membranes (MAMs). Biochim Biophys Acta.
1858:615–627. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marchi S and Pinton P: Alterations of
calcium homeostasis in cancer cells. Curr Opin Pharmacol. 29:1–6.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Monteith GR, Prevarskaya N and
Roberts-Thomson SJ: The calcium-cancer signalling nexus. Nat Rev
Cancer. 17:367–380. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Landes T and Martinou JC: Mitochondrial
outer membrane permeabilization during apoptosis: The role of
mitochondrial fission. Biochim Biophys Acta. 1813:540–545. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Elgass K, Pakay J, Ryan MT and Palmer CS:
Recent advances into the understanding of mitochondrial fission.
Biochim Biophys Acta. 1833:150–161. 2013. View Article : Google Scholar
|
|
40
|
Twig G and Shirihai OS: The interplay
between mitochondrial dynamics and mitophagy. Antioxid Redox
Signal. 14:1939–1951. 2011. View Article : Google Scholar :
|
|
41
|
Chen H, Chomyn A and Chan DC: Disruption
of fusion results in mitochondrial heterogeneity and dysfunction. J
Biol Chem. 280:26185–26192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hoppins S, Lackner L and Nunnari J: The
machines that divide and fuse mitochondria. Annu Rev Biochem.
76:751–780. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Akita M, Suzuki-Karasaki M, Fujiwara K,
Nakagawa C, Soma M, Yoshida Y, Ochiai T, Tokuhashi Y and
Suzuki-Karasaki Y: Mitochondrial division inhibitor-1 induces
mitochondrial hyper-fusion and sensitizes human cancer cells to
TRAIL-induced apoptosis. Int J Oncol. 45:1901–1912. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Suzuki-Karasaki Y, Fujiwara K, Saito K,
Suzuki-Karasaki M, Ochiai T and Soma M: Distinct effects of TRAIL
on the mitochondrial network in human cancer cells and normal
cells: Role of plasma membrane depolarization. Oncotarget.
6:21572–21588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saito K, Asai T, Fujiwara K, Sahara J,
Koguchi H, Fukuda N, Suzuki-Karasaki M, Soma M and Suzuki-Karasaki
Y: Tumor-selective mitochondrial network collapse induced by
atmospheric gas plasma-activated medium. Oncotarget. 7:19910–19927.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Takata N, Ohshima Y, Suzuki-Karasaki M,
Yoshida Y, Tokuhashi Y and Suzuki-Karasaki Y: Mitochondrial
Ca2+ removal amplifies TRAIL cytotoxicity toward
apoptosis-resistant tumor cells via promotion of multiple cell
death modalities. Int J Oncol. 51:193–203. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ohshima Y, Takata N, Suzuki-Karasaki M,
Yoshida Y, Tokuhashi Y and Suzuki-Karasaki Y: Disrupting
mitochondrial Ca2+ homeostasis causes tumor-selective
TRAIL sensitization through mitochondrial network abnormalities.
Int J Oncol. 51:1146–1158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Judée F, Fongia C, Ducommun B, Yousfi M,
Lobjois V and Merbahi N: Short and long time effects of low
temperature Plasma Activated Media on 3D multicellular tumor
spheroids. Sci Rep. 6:214212016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Utsumi F, Kajiyama H, Nakamura K, Tanaka
H, Mizuno M, Toyokuni S, Hori M and Kikkawa F: Variable
susceptibility of ovarian cancer cells to non-thermal
plasma-activated medium. Oncol Rep. 35:3169–3177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Adachi T, Kano A, Nonomura S, Kamiya T and
Hara H: Histone deacetylase inhibitors stimulate the susceptibility
of A549 cells to a plasma-activated medium treatment. Arch Biochem
Biophys. 606:120–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kurake N, Tanaka H, Ishikawa K, Kondo T,
Sekine M, Nakamura K, Kajiyama H, Kikkawa F, Mizuno M and Hori M:
Cell survival of glioblastoma grown in medium containing hydrogen
peroxide and/or nitrite, or in plasma-activated medium. Arch
Biochem Biophys. 605:102–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Suzuki Y, Inoue T, Murai M,
Suzuki-Karasaki M, Ochiai T and Ra C: Depolarization potentiates
TRAIL-induced apoptosis in human melanoma cells: Role for
ATP-sensitive K+ channels and endoplasmic reticulum
stress. Int J Oncol. 41:465–475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Suzuki-Karasaki M, Ochiai T and
Suzuki-Karasaki Y: Crosstalk between mitochondrial ROS and
depolarization in the potentiation of TRAIL-induced apoptosis in
human tumor cells. Int J Oncol. 44:616–628. 2014. View Article : Google Scholar
|
|
54
|
McCarthy JV and Cotter TG: Cell shrinkage
and apoptosis: A role for potassium and sodium ion efflux. Cell
Death Differ. 4:756–770. 1997. View Article : Google Scholar
|
|
55
|
Lang F, Föller M, Lang K, Lang P, Ritter
M, Vereninov A, Szabo I, Huber SM and Gulbins E: Cell volume
regulatory ion channels in cell proliferation and cell death.
Methods Enzymol. 428:209–225. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bortner CD, Gomez-Angelats M and Cidlowski
JA: Plasma membrane depolarization without repolarization is an
early molecular event in anti-Fas-induced apoptosis. J Biol Chem.
276:4304–4314. 2001. View Article : Google Scholar
|
|
57
|
Nolte F, Friedrich O, Rojewski M, Fink RH,
Schrezenmeier H and Körper S: Depolarisation of the plasma membrane
in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in
myeloid cells. FEBS Lett. 578:85–89. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yin W, Li X, Feng S, Cheng W, Tang B, Shi
YL and Hua ZC: Plasma membrane depolarization and Na, K-ATPase
impairment induced by mitochondrial toxins augment leukemia cell
apoptosis via a novel mitochondrial amplification mechanism.
Biochem Pharmacol. 78:191–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jardin I and Rosado JA: STIM and calcium
channel complexes in cancer. Biochim Biophys Acta. 1863:1418–1426.
2016. View Article : Google Scholar
|
